Capital Bank & Trust CO Abb Vie Inc. Transaction History

Capital Bank & Trust CO

$0
Q3 2022

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $5.29 Million - $5.89 Million	-50,239 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $97,696 - $107,552	955 Added 1.94%	50,239 $5.44 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $485,515 - $655,497	6,032 Added 13.95%	49,284 $5.28 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $228,864 - $268,611	-2,664 Reduced 5.8%	43,252 $3.79 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $4,915 - $6,578	-67 Reduced 0.15%	45,916 $4.51 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $258 - $391	-4 Reduced 0.01%	45,983 $3.5 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $30,871 - $38,627	-428 Reduced 0.92%	45,987 $4.07 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $14,170 - $17,037	-225 Reduced 0.48%	46,415 $3.52 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $555,624 - $710,218	8,457 Added 22.15%	46,640 $3.39 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $591,586 - $696,268	-7,669 Reduced 16.73%	38,183 $3.08 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $11,132 - $13,729	143 Added 0.31%	45,852 $4.23 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $4,178 - $4,645	-47 Reduced 0.1%	45,709 $4.32 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $2.8 Million - $3.31 Million	31,162 Added 213.53%	45,756 $4.24 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $6,900 - $9,240	-75 Reduced 0.51%	14,594 $1.38 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $141,057 - $154,680	1,575 Added 12.03%	14,669 $1.42 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $171,551 - $219,124	2,456 Added 23.09%	13,094 $1.16 Million
Q2 2017 Aug 14, 2017	BUY	N/A	10,638	10,638 $771,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital Bank & Trust CO with notifications on news.

Account